COMP <GO>
OFLX vs TMO // FORWARD P/E MULTIPLE
Omega Flex Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: OFLX 6
— TMO 5
▲ FORWARD P/E MULTIPLE LEADER: OFLX
LAST: $26.44 (+5.93%) • MKT CAP: $266.9M
forward-pe
16.7x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
forward-pe
36.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OFLX VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OFLX | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 60.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 43.20% | 9.30% | +33.90 | OFLX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.6x | 30.4x | -18.80 | OFLX | /valuation <GO> |
| Free Cash Flow Yield | 5.75% | 2.40% | +3.35 | OFLX | /fcf-yield <GO> |
| Operating Margin | 17.20% | 17.40% | -0.20 | TMO | /operating-margins <GO> |
| Net Profit Margin | 15.10% | 15.10% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -3.30% | 3.90% | -7.20 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.14% | 0.24% | +4.90 | OFLX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.87 | 4.50 | +6.37 | OFLX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.9 | 62.9 | -5.00 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 16.7x | 36.3x | -19.60 | OFLX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $266.9M | $262.22B | -$261.95B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OFLX REV | TMO REV | OFLX GROSS % | TMO GROSS % | OFLX FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $98.3M | $44.56B | 60.0% | — | $15.4M | $6.29B |
| FY 2024 | $101.7M | $42.88B | 61.2% | — | $18.9M | $7.27B |
| FY 2023 | $111.5M | $42.86B | — | — | $23.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OFLX // BETA —
TMO // BETA 0.94